Glyxambi
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 476
  • Home
  • Print this page
  • Email this page


 
   Table of Contents      
ONE MINUTE OPHTHALMOLOGY
Year : 2019  |  Volume : 67  |  Issue : 9  |  Page : 1391

Bilateral granulomatous uveitis in an elderly female


1 Department of Glaucoma, Vittala International Institute of Ophthalmology and Prabha Eye Clinic and Research Centre, Bengaluru, Karnataka, India
2 Department of Uveitis and Ocular Inflammation, Vittala International Institute of Ophthalmology and Prabha Eye Clinic and Research Centre, Bengaluru, Karnataka, India

Date of Web Publication22-Aug-2019

Correspondence Address:
Dr. Kalpana Babu
504, 40th Cross, Jayanagar 8th Block, Bangalore - 560 070, Karnataka
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijo.IJO_1427_19

Rights and Permissions

How to cite this article:
Kattige J, Konana VK, Babu K. Bilateral granulomatous uveitis in an elderly female. Indian J Ophthalmol 2019;67:1391

How to cite this URL:
Kattige J, Konana VK, Babu K. Bilateral granulomatous uveitis in an elderly female. Indian J Ophthalmol [serial online] 2019 [cited 2019 Sep 22];67:1391. Available from: http://www.ijo.in/text.asp?2019/67/9/1391/265087



An 80-year-old lady in good health with primary angle closure glaucoma (OU) since 15 years and on topical levobunalol 0.5%, bimatoprost 0.03%, and dorzolomide 2% had her intraocular pressure (IOP) under control. During her visit in January 2019, her visual fields showed progression and IOP recorded was 20 and 26 mmHg in OD and OS, respectively. Bimatoprost 0.03% was stopped and changed to brimonidine 0.2%. Two weeks after the use of brimonidine, she presented with raised IOP (26 mmHg) in both eyes with granulomatous anterior uveitis [Figure 1]a and [Figure 1]b, with no posterior segment involvement.
Figure 1: (a) Anterior segment photograph of the right eye showing medium-sized keratic precipitates on the endothelium (white arrow). Pigments can be seen over the anterior capsule of the lens (star). (b) Anterior segment photograph of the left eye showing medium-sized keratic precipitates on the endothelium (white arrow)

Click here to view



  What is your Next Step? Top


  1. Investigate for systemic causes of granulomatous uveitis
  2. Start on topical steroids
  3. Start on systemic steroids or immunosuppressants if the inflammation is not under control
  4. Stop brimonidine.



  Correct Answer: D Top



  Findings Top


The patient was asked to stop brimonidine eye drops and was started on prednisolone acetonide 1% eye drops. Investigations to rule out systemic causes of granulomatous uveitis like Mantoux test, chest X-ray, serum angiotensin converting enzyme, and venereal disease research laboratory test were not contributory. One week later, she had no signs of ocular inflammation. She had a similar history in the past on changing the antiglaucoma medication. At 3 months of follow-up after stopping the drug, there were no signs of inflammation in both eyes.


  Diagnosis Top


Brimonidine-induced granulomatous uveitis


  Discussion Top


Allergic conjunctivitis and skin excoriation are the most common side effects of brimonidine.[1] Although rare, brimonidine can cause granulomatous uveitis in the elderly.[2],[3] It usually occurs 7–12 months after starting the drug and is seen in elderly patients. The uveitis usually resolves with drug discontinuation. In our case, the uveitis occurred 2 weeks after starting the drug. It has been hypothesized that brimonidine induces T-cell/macrophage activation and interaction.[3] Thus, though rare, granulomatous uveitis can occur with brimonidine and clinicians need to be aware of its usage in elderly.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Katz LJ. Brimonidine tartrate 0.2% twice dailyvstimolol 0.5% twice daily: 1-year results in glaucoma patients. Brimonidine Study Group. Am J Ophthalmol 1999;127:20-6.  Back to cited text no. 1
    
2.
Goyal R, Ram AR. Brimonidine tartrate 0.2% (Alphagan) associated granulomatous anterior uveitis. Eye (Lond) 2000;14:908-10.  Back to cited text no. 2
    
3.
Beltz J, Zamir E. Brimonidine induced anterior uveitis. Ocul Immunol Inflamm 2016;24:128-33.  Back to cited text no. 3
    


    Figures

  [Figure 1]



 

Top
 
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
What is your Nex...
Correct Answer: D
Findings
Diagnosis
Discussion
References
Article Figures

 Article Access Statistics
    Viewed771    
    Printed6    
    Emailed0    
    PDF Downloaded279    
    Comments [Add]    

Recommend this journal